Pantazis-Michail Voutsinas

ORCID: 0000-0003-2553-7317
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • Respiratory Support and Mechanisms
  • Intensive Care Unit Cognitive Disorders
  • Sepsis Diagnosis and Treatment

Laiko General Hospital of Athens
2023

National and Kapodistrian University of Athens
2023

Background: Nirmatrelvir/ritonavir (NMV/r) and three-day course remdesivir (3RDV) have been approved as early treatments for COVID-19 outpatients not requiring supplemental oxygen. Real-life data on the efficacy of antivirals among immunocompromised patients or directly comparing their effectiveness in preventing hospitalization and/or death are scarce. Methods: Prospective, observational study conducted a tertiary care hospital, from 1 January 2022 until 15 March 2023, during prevalence...

10.3390/v15071515 article EN cc-by Viruses 2023-07-07

Background. High-flow nasal cannula (HFNC) is an oxygen delivery method shown to reduce the risk of intubation and mortality in patients with type 1 respiratory failure. The ROX-index score can predict HFNC This study aims evaluate sequential assessments as predictors failure mortality. Methods. Prospective observational single-center including all adult positive SARS-CoV-2 PCR placed under from 1st November 2020 31st May 2021, hemodynamic instability or unable tolerate were excluded....

10.1155/2023/7474564 article EN cc-by Canadian Respiratory Journal 2023-02-08
Coming Soon ...